| Catalog | name | Description | price |
|---|---|---|---|
| R-M2-9491 | DMG-PEG5K-SGLYKVAYDWQH | DMG-PEG5K-SGLYKVAYDWQH for various biomedical applications. This structure illustrates significant potential in targeted drug delivery, gene therapy, vaccine design, and other therapeutic environments where specificity and efficacy are crucial. | price> |
| R-M2-9492 | Cholesterol-PEG2000-SNTALPSKFYGYGGGSC | Cholesterol-PEG2000-SNALPSKFYGYGGSC can be applied to Targeted Drug Delivery, Nanocarriers for Hydrophobic Drugs,Gene Delivery,Improved Pharmacokinetics,Vaccine Development,In Vivo Imaging etc. | price> |
| R-M2-9493 | DMG-PEG2000-SNTALPSKFYGYGGGSC | DMG-PEG2000-SNTALPSKFYGYGGGSC is a versatile bioconjugate that combines a lipid anchor (DMG), a hydrophilic polymer (PEG), and a targeting peptide, creating a platform suitable for advanced drug delivery applications. This specific structure can enhance the delivery efficiency of therapeutic agents while minimizing side effects, making it particularly useful in fields like cancer therapy, gene therapy, and vaccine development. | price> |
| R-M2-9495 | Cholesterol-PEG2K-LSALTPSPSWLKYKAL | Cholesterol-PEG2K-LSALTPSPSWLKYKAL is a versatile bioconjugate that can be adapted for a wide range of applications, particularly in drug delivery and therapeutic development. The combination of cholesterol, PEG, and a bioactive peptide has the potential to enhance the delivery and efficacy of therapeutic agents, improve pharmacokinetics, and target specific cells or tissues for a more effective treatment approach. | price> |
| R-M2-9496 | DMG-PEG2K-LSALTPSPSWLKYKAL | DMG-PEG2K-LSALTPSPSWLKYKAL represents a versatile bioconjugate with promising applications in drug delivery, gene therapy, and vaccine development,targeted therapy. | price> |
| R-M2-9497 | Cholesterol-PEG2K-peptide(AC-ELKVMEKEL-NH2) | Cholesterol-PEG2K-AC-ELKVMEKEL-NH2 represents a versatile bioconjugate with promising applications across various biomedical fields, notably in drug and gene delivery, vaccine formulation, and targeted therapies. The combination of cholesterol for membrane interaction, PEG for solubility and stability, and the bioactive peptide for cellular uptake presents a powerful tool for enhancing the efficacy and specificity of therapeutic agents. | price> |
| R-M2-9498 | DMG-PEG2K-peptide(AC-ELKVMEKEL-NH2) | DMG-PEG2K-AC-ELKVMEKEL-NH2 is a sophisticated bioconjugate designed to enhance the delivery and efficacy of therapeutic agents. By combining DMG for solubility and metabolic benefits, PEG for stability and pharmacokinetics, and a bioactive peptide for targeting and cellular uptake, this conjugate holds significant promise for applications in drug delivery, gene therapy, vaccine development, and more. | price> |
| R-M2-9499 | DMG-PEG2000-TK-PEG2000-KLVFFAED | DMG-PEG2000-TK-PEG2000-KLVFFAED/DMG-PEG2000-thioketal-PEG2000-KLVFFAED is a versatile bioconjugate that synergizes several elements for enhanced drug delivery, targeting, and therapeutic efficacy. Its design suggests significant potential in various domains, including targeted cancer therapies, immunotherapy, and peptide-based drug delivery systems. | price> |
| R-M2-9500 | Cholesterol-PEG2000-TK- PEG2000-KLVFFAED | Cholesterol-PEG2000-TK-PEG2000-KLVFFAED/Cholesterol-PEG2000-thioketal-PEG2000-KLVFFAED is a multifunctional bioconjugate combining the beneficial properties of cholesterol, polyethylene glycol, a thrombin-cleavable peptide, and a cell-penetrating peptide. This structure allows for enhanced drug delivery, targeted therapeutics, and potential applications in immunotherapy and gene therapy. | price> |
| R-M2-9501 | Cholesterol-PEG2000-MG1(C-HHSSSAR-C) | Cholesterol-PEG2000-MG1(C-HHSSSAR-C) represents a versatile bioconjugate platform combining lipophilicity, hydrophilicity, and biological targeting capabilities. Its formulation can facilitate efficient drug delivery, targeted therapies, and enhanced biological interactions, making it potentially valuable across various biomedical applications, including cancer therapy, gene delivery, and immunotherapy. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


